About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Nashville | 10,824 Studies Near You

Clinical TrialsNashville

Clinical Trials in Nashville

Discover 10,824 clinical trials near Nashville, Tennessee. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 4701-4720 of 10,824 trials

CompletedCitrulline in Severe SepsisThis is a randomized, double-blind, placebo-controlled, phase 2 study to evaluate biochemical, clinical, and safety effects of 2 doses of intravenous L-citrulline compared to…NCT01474863·Nashville, Tennessee CompletedA follow-on Safety Study in Subjects With Crohn's Disease Who Have Previously Been Withdrawn From the Double-blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425] Due to an Exacerbation of Crohn's DiseaseA follow-on safety study in subjects with Crohn's Disease who have previously been withdrawn from the double-blind study CDP870-031 \[NCT00152490\] or CDP870-032 \[NCT00152425\]…NCT00160706·Birmingham, Alabama and 140 others

Find Trials by Condition in Nashville

Breast Cancerin Nashville Lung Cancerin Nashville Prostate Cancerin Nashville Colorectal Cancerin Nashville Melanomain Nashville Leukemiain Nashville Lymphomain Nashville Pancreatic Cancerin Nashville Ovarian Cancerin Nashville Brain Cancerin Nashville

Data from ClinicalTrials.govTerms

UnknownKRT-232 Versus Best Available Therapy for the Treatment of Subjects With Myelofibrosis Who Are Relapsed or Refractory to JAK Inhibitor TreatmentThis study evaluates KRT-232, a novel oral small molecule inhibitor of MDM2, for the treatment of patients with myelofibrosis (MF) who no longer benefit from treatment with a JAK…NCT03662126·Birmingham, Alabama and 190 others

CompletedA Phase 2a of RSLV-132 in Subjects With Systemic Lupus Erythematosus (SLE)This study evaluates the impact of 13 bi-weekly intravenous infusions of RSLV-132 on the cutaneous manifestations in subjects with systemic lupus erythematosus.NCT02660944·El Cajon, California and 15 others

RecruitingEfficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic PhenotypeThis is a parallel, Phase 2b/Phase 3, 3-arm study to investigate the efficacy, safety, and tolerability of subcutaneous (SC) treatment with lunsekimig compared with placebo in…NCT07190209·Chandler, Arizona and 293 others

CompletedSorafenib and Erlotinib or Sorafenib Alone in Advanced Non-Small Cell Lung Cancer Progressing on ErlotinibThis is a randomized, open-label, multi-center, Phase II study of treatment of patients with advanced NSCLC who have progressed on erlotinib with the combination of sorafenib and…NCT00609804·Fort Myers, Florida and 15 others

CompletedAutologous Muscle Derived Cells for Female Urinary Sphincter RepairThis randomized, double-blind, placebo-controlled, multicenter, confirmatory study will evaluate the efficacy and safety of Cook MyoSite Incorporated Autologous Muscle-Derived…NCT01893138·Phoenix, Arizona and 28 others

CompletedA Pharmacokinetic Study of RO5185426 in Combination With a Drug Cocktail in Patients With Metastatic MelanomaThis open-label single-arm study will evaluate the effect of RO5185426 \[RG7204; PLEXXIKON: PLX4032\] on the pharmacokinetics of five CYP450 substrates (caffeine, warfarin +…NCT01001299·Los Angeles, California and 4 others

TerminatedFPA150 in Patients With Advanced Solid TumorsThis is a multi-center study to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and preliminary efficacy of FPA150, an anti-B7H4 antibody alone or…NCT03514121·Scottsdale, Arizona and 17 others

TerminatedImaging Activated Macrophages in the LungsTo test whether folate-based positron emission tomography (PET) imaging using 68Ga-EC2115 can differentiate chronic obstructive pulmonary disease (COPD) patients from control…NCT03494114·Nashville, Tennessee

RecruitingIdentifying Effective and Cost-Conscious Maintenance Daratumumab DosingThis phase II trial tests daratumumab given at a reduced frequency with lenalidomide for maintenance therapy for the cost effective treatment of patients with multiple myeloma…NCT07485647·Nashville, Tennessee

RecruitingDESTINY-PANTUMOUR04This study will evaluate the effectiveness of T-DXd in patients with HER2-positive (IHC 3+) locally advanced, unresectable, or metastatic solid tumors who have received prior…NCT07124000·Birmingham, Alabama and 17 others

CompletedSafety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years OldEvaluate safety and immunogenicity of three influenza vaccines in children ages greater than 4 years old to less than 18 years old.NCT01992107·Huntsville, Alabama and 87 others

CompletedGRAVITAS-301: A Study of Itacitinib or Placebo in Combination With Corticosteroids for Treatment of Acute Graft-Versus-Host DiseaseThe purpose of this study is to evaluate itacitinib or placebo in combination with corticosteroids as first-line treatment of participants with Grade II to IV acute…NCT03139604·La Jolla, California and 128 others

CompletedA Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder CancerThis is a study that will test how an experimental drug (enfortumab vedotin) affects patients with cancer of the urinary system (urothelial cancer).NCT03219333·Anchorage, Alaska and 80 others

CompletedIrinotecan in Patients With Advanced Metastatic Breast Cancer Who Have Experienced Failure of an Anthracycline, a Taxane, and CapecitabineThe purpose of this phase II, randomized, open-label clinical trial is to study 2 schedules of single-agent Irinotecan in women with metastatic breast cancer who have experienced…NCT00072852·Mobile, Alabama and 65 others

TerminatedA Study of K-645 in the Treatment of Multiple Migraine AttacksThis is a multicenter, randomized, double-blind, placebo-controlled, 3-period crossover study to evaluate the safety, tolerability, and efficacy of two dose levels of K-645 in the…NCT07116499·Oceanside, California and 17 others

Terminated(VELA) Study of BLU-222 in Advanced Solid TumorsThis is a Phase 1/2, open-label, first-in-human (FIH) study designed to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and anticancer activity of…NCT05252416·Little Rock, Arkansas and 22 others

RecruitingA Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and AdolescentsThe purpose of this study is to evaluate the long-term safety and tolerability of Xanomeline and Trospium Chloride for the treatment of psychiatric disorders in children and…NCT07424404·Dothan, Alabama and 93 others

Active not recruitingTrial of Indication-Based Transfusion of Red Blood Cells in ECMOTITRE - Trial of Indication-based Transfusion of Red Blood Cells in ECMO, is a multicenter, prospective, randomized clinical trial.NCT05405426·Phoenix, Arizona and 21 others

PreviousPage 236 of 542Next

Diabetes

in Nashville

Heart Diseasein Nashville